His main research concerns Asthma, Immunology, Internal medicine, Atopy and Wheeze. His Asthma study integrates concerns from other disciplines, such as Physical therapy, Randomized controlled trial, Pediatrics and Allergy. His study looks at the relationship between Pediatrics and topics such as Epidemiology, which overlap with Cross-sectional study, Global health and Mortality rate.
His study on Immunology also encompasses disciplines like
His scientific interests lie mostly in Asthma, Internal medicine, Pediatrics, Immunology and Tuberculosis. His study looks at the relationship between Asthma and fields such as Physical therapy, as well as how they intersect with chemical problems. Guy B. Marks has researched Internal medicine in several fields, including Endocrinology, Surgery and Cardiology.
His work investigates the relationship between Pediatrics and topics such as Epidemiology that intersect with problems in Demography. His Immunology study combines topics from a wide range of disciplines, such as Sputum and Mite. His Tuberculosis research integrates issues from Public health, Incidence, Disease and Intensive care medicine.
Guy B. Marks mostly deals with Asthma, Environmental health, Coronavirus disease 2019, Tuberculosis and Public health. His work deals with themes such as Nursing, Exacerbation, Disease, Low birth weight and Physical therapy, which intersect with Asthma. His Disease study frequently draws connections between related disciplines such as Stakeholder engagement.
His research integrates issues of Obstructive lung disease, Air pollution, Poverty, Socioeconomic status and Risk factor in his study of Environmental health. In Obstructive lung disease, Guy B. Marks works on issues like Body mass index, which are connected to Pediatrics. His research in Tuberculosis intersects with topics in Psychological intervention and Internal medicine, Randomized controlled trial, Incidence.
Disease, Tuberculosis, Risk analysis, Air pollution and Internal medicine are his primary areas of study. Guy B. Marks integrates Disease and Government in his research. Guy B. Marks integrates Tuberculosis and Context in his studies.
His study in Risk analysis is interdisciplinary in nature, drawing from both Viral transmission, Case finding, Contact Investigation and 2019-20 coronavirus outbreak. He works mostly in the field of Air pollution, limiting it down to topics relating to Public health and, in certain cases, Incidence and Health services. His Internal medicine research includes themes of Latent tuberculosis and Institutional review board.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano;Mohsen Naghavi;Kyle Foreman;Stephen Lim.
The Lancet (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J.L. Murray;Theo Vos;Rafael Lozano;Mohsen Naghavi.
The Lancet (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos;Abraham D. Flaxman;Mohsen Naghavi;Rafael Lozano.
The Lancet (2012)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos;Ryan M. Barber;Brad Bell;Amelia Bertozzi-Villa.
The Lancet (2015)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Mohammad H Forouzanfar;Lily Alexander;H Ross Anderson;Victoria F Bachman.
The Lancet (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi;Haidong Wang;Rafael Lozano;Adrian Davis.
The Lancet (2015)
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
A Sonia Buist;Mary Ann McBurnie;William M. Vollmer;Suzanne Gillespie.
The Lancet (2007)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A Roth;Gregory A Roth;Degu Abate;Kalkidan Hassen Abate;Solomon M Abay.
The Lancet (2018)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013 : a systematic analysis for the Global Burden of Disease Study 2013
Mohammad H. Forouzanfar;Lily Alexander;H. Ross Anderson;Victoria F. Bachman.
The Lancet (2015)
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Mark R. Elkins;Michael Robinson;Barbara R. Rose;Colin Harbour.
The New England Journal of Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Woolcock Institute of Medical Research
University of Newcastle Australia
Royal Prince Alfred Hospital
University of Sydney
Karolinska Institute
Monash University
University of Queensland
Queensland University of Technology
Royal Adelaide Hospital
University of Sydney
University of Crete
University of Copenhagen
Central Queensland University
Virginia Tech
Seoul National University
Institute for Basic Science
University of Arkansas for Medical Sciences
University of Sheffield
Emory University
Spanish National Research Council
University of Oxford
Northeastern University
University of Southern California
Erasmus University Rotterdam
Karolinska Institute
University of Exeter